Buffett just messed things up for Teva short-sellers
Add BT as a preferred sourceIT'S not like there was any real risk in shorting an easy target like Teva Pharmaceutical Industries. Warren Buffett could come along to destroy your bet, but what were the odds of that happening?
Oops.
It's not a happy Valentine's Day for Teva short-sellers. After the market closed Wednesday, a filing from Buffett's Berkshire Hathaway disclosed that it made only one new investment during the latest quarter. Unluckily for Teva bears, it was the Israeli generic-drug maker they've been betting against to the tune of US$1.2 billion.
TRENDING NOW
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
MSCI drops S-E Asian heavyweights Sembcorp, GoTo and Ayala Land from global benchmarks
